Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Endothelial Ischemia and Reperfusion Injury (MetFMD)
NCT01610401Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started May 2012; status: completed.
02
Drugs
metformin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01610401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610401.